Jessica E Miller

No ORCID on file · 21 papers in corpus · active 2016-2024

Study types

  • article 12
  • review 4
  • other 3
  • book-chapter 1
  • preprint 1

Condition tags

  • endometriosis 21
  • infertility 4
  • chronic_pelvic_pain 3
  • endometrioma 1
  • die_deep_infiltrating 1
  • adenomyosis 1
other 2024
Journal of immunology (Baltimore, Md. : 1950) ·doi:10.4049/jimmunol.2400018

Endometriosis is a chronic inflammatory disease in which endometrial-like tissue grows ectopically, resulting in pelvic pain and infertility. IL-23 is a key contributor in the development and differentiation of TH17 cells, driving TH17 cell…

preprint 2023
·doi:10.1101/2023.12.07.570652

Abstract Endometriosis is a chronic inflammatory disease where endometrial-like tissue grows ectopically, resulting in pelvic pain and infertility. Interleukin (IL)-23 is established as a key contributor in the development and differentiati…

article 2023
Frontiers in immunology ·doi:10.3389/fimmu.2023.1089098

Endometriosis is an estrogen dominant, chronic inflammatory disease characterized by the growth of endometrial-like tissue outside of the uterus. The most common symptoms experienced by patients include manifestations of chronic pelvic pain…

article 2022
·doi:10.17615/me81-9148

Endometriosis is an estrogen dependent, chronic inflammatory disease characterized by the growth of endometrial lining outside of the uterus. Mast cells have emerged as key players in regulating not only allergic responses but also other me…

article 2022
Frontiers in immunology ·doi:10.3389/fimmu.2022.961599

Endometriosis is an estrogen dependent, chronic inflammatory disease characterized by the growth of endometrial lining outside of the uterus. Mast cells have emerged as key players in regulating not only allergic responses but also other me…

review 2022
Trends in molecular medicine ·doi:10.1016/j.molmed.2022.04.006

IL-33 is a member of the IL-1 family and was first identified as an alarmin that acts at mucosal barrier sites. However, IL-33 is now understood to be a pleiotropic cytokine that acts on a variety of immune and non-immune cell types to prom…

article 2022
F&S science ·doi:10.1016/j.xfss.2022.04.007

OBJECTIVE: To identify immune cells, cytokines, and immune cell transcriptome in the menstrual effluent (ME) of women with endometriosis compared with that of healthy donors. DESIGN: Live immune cells were isolated from human ME samples an…

other 2021
JCI insight ·doi:10.1172/jci.insight.149699

Chronic inflammation and localized alterations in immune cell function are suspected to contribute to the progression of endometriosis and its associated symptoms. In particular, the alarmin IL-33 is elevated in the plasma, peritoneal fluid…

article 2021
·doi:10.4049/jimmunol.206.supp.12.05

Abstract Introduction: Chronic inflammation drives endometriosis (EM) and its associated symptoms. Interleukin (IL)-33, has gained therapeutic interest as it is elevated in the plasma, peritoneal fluid (PF), and lesions of EM patients. Howe…

article 2021
F&S science ·doi:10.1016/j.xfss.2021.09.005

Objective To determine the involvement of the endocannabinoid (EC) family member in the pathophysiology of endometriosis (EMS). Design Mass spectrometry analysis of plasma and tissue samples from patients with EMS, controls, and a mouse mod…

article 2021
Frontiers in reproductive health ·doi:10.3389/frph.2021.726936

Endometriosis (EM) is characterized by the growth of endometrium-like tissue outside the uterus, leading to chronic inflammation and pelvic pain. Lesion proliferation, vascularization, and associated inflammation are the hallmark features o…

other 2020
Frontiers in immunology ·doi:10.3389/fimmu.2020.00108

Endometriosis is a debilitating gynecological disease characterized by the extrauterine presence of endometrial-like tissues located on the peritoneal membrane and organs of the pelvic cavity. Notably, dysfunctional immune activation in wom…

article 2020
·doi:10.17615/0gze-en40
book-chapter 2019
·doi:10.1007/978-3-030-28584-5_10
article 2019
JCI insight ·doi:10.1172/jci.insight.128846

With multifactorial etiologies, combined with disease heterogeneity and a lack of suitable diagnostic markers and therapy, endometriosis remains a major reproductive health challenge. Extracellular vesicles (EVs) have emerged as major contr…

article 2019
FASEB journal : official publication of the Federation of American Societies for Experimental Biology ·doi:10.1096/fj.201902272r

Endometriosis is a chronic inflammatory, gynecological disease characterized by the presence of endometrial-like tissue lesions outside of the uterus. Neutrophils are elevated in the systemic circulation and peritoneal fluid of endometriosi…

article 2019
·doi:10.4049/jimmunol.202.supp.182.19

Abstract Introduction Endometriosis (EM) is a chronic inflammatory disease categorized by the growth of endometrial tissue on the ovaries, peritoneal wall and other internal organs. Despite it’s prevalence (176 million women worldwide), the…

review 2018
Trends in molecular medicine ·doi:10.1016/j.molmed.2018.07.004

Endometriosis is a chronic, inflammatory, estrogen-dependent disease characterized by the growth of endometrial tissue outside of the uterine cavity. Although the etiology of endometriosis remains elusive, immunological dysfunction has been…

article 2017
Scientific reports ·doi:10.1038/s41598-017-18224-x

Endometriosis is a debilitating condition that is categorized by the abnormal growth of endometrial tissue outside the uterus. Although the pathogenesis of this disease remains unknown, it is well established that endometriosis patients exh…

review 2017
The American journal of pathology ·doi:10.1016/j.ajpath.2017.01.017

RNA-binding proteins are key regulatory molecules involved primarily in post-transcriptional gene regulation of RNAs. Post-transcriptional gene regulation is critical for adequate cellular growth and survival. Recent reports have shown key …

review 2016
Oncotarget ·doi:10.18632/oncotarget.12577

// Jessica E. Miller 1 , Soo Hyun Ahn 1 , Stephany P. Monsanto 1 , Kasra Khalaj 1 , Madhuri Koti 1 and Chandrakant Tayade 1 1 Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, Ontario, Canada Correspondence to: …